Literature DB >> 33211820

A Psychometric Evaluation of the Motor-Behavioral Assessment Scale for Use as an Outcome Measure in Rett Syndrome Clinical Trials.

Melissa Raspa1, Carla M Bann1, Angela Gwaltney1, Timothy A Benke2, Cary Fu3, Daniel G Glaze4, Richard Haas5, Peter Heydemann6, Mary Jones7, Walter E Kaufmann8, David Lieberman9, Eric Marsh9, Sarika Peters10, Robin Ryther11, Shannon Standridge12, Steven A Skinner13, Alan K Percy14, Jeffrey L Neul15.   

Abstract

Rett syndrome (RTT) is a neurodevelopmental disorder that primarily affects females. Recent work indicates the potential for disease modifying therapies. However, there remains a need to develop outcome measures for use in clinical trials. Using data from a natural history study (n = 1,075), we examined the factor structure, internal consistency, and validity of the clinician-reported Motor Behavior Assessment scale (MBA). The analysis resulted in a five-factor model: (1) motor dysfunction, (2) functional skills, (3) social skills, (4) aberrant behavior, and (5) respiratory behaviors. Item Response Theory (IRT) analyses demonstrated that all items had acceptable discrimination. The revised MBA subscales showed a positive relationship with parent reported items, age, and a commonly used measure of clinical severity in RTT, and mutation type. Further work is needed to evaluate this measure longitudinally and to add items related to the RTT phenotype. ©AAIDD.

Entities:  

Keywords:  Rett syndrome; clinical trial; outcome measure; psychometrics

Year:  2020        PMID: 33211820      PMCID: PMC7778880          DOI: 10.1352/1944-7558-125.6.493

Source DB:  PubMed          Journal:  Am J Intellect Dev Disabil        ISSN: 1944-7558


  34 in total

1.  The Rett Syndrome Behaviour Questionnaire (RSBQ): refining the behavioural phenotype of Rett syndrome.

Authors:  Rebecca H Mount; Tony Charman; Richard P Hastings; Sheena Reilly; Hilary Cass
Journal:  J Child Psychol Psychiatry       Date:  2002-11       Impact factor: 8.982

2.  Anxiety-like behavior in Rett syndrome: characteristics and assessment by anxiety scales.

Authors:  Katherine V Barnes; Francesca R Coughlin; Heather M O'Leary; Natalie Bruck; Grace A Bazin; Emily B Beinecke; Alexandra C Walco; Nicole G Cantwell; Walter E Kaufmann
Journal:  J Neurodev Disord       Date:  2015-09-15       Impact factor: 4.025

3.  Patient-Reported Outcome and Observer-Reported Outcome Assessment in Rare Disease Clinical Trials: An ISPOR COA Emerging Good Practices Task Force Report.

Authors:  Katy Benjamin; Margaret K Vernon; Donald L Patrick; Eleanor Perfetto; Sandra Nestler-Parr; Laurie Burke
Journal:  Value Health       Date:  2017 Jul - Aug       Impact factor: 5.725

4.  Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.

Authors:  R E Amir; I B Van den Veyver; M Wan; C Q Tran; U Francke; H Y Zoghbi
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

Review 5.  Rett Syndrome: A Genetic Update and Clinical Review Focusing on Comorbidities.

Authors:  Wendy A Gold; Rahul Krishnarajy; Carolyn Ellaway; John Christodoulou
Journal:  ACS Chem Neurosci       Date:  2017-12-15       Impact factor: 4.418

Review 6.  Clinical and biological progress over 50 years in Rett syndrome.

Authors:  Helen Leonard; Stuart Cobb; Jenny Downs
Journal:  Nat Rev Neurol       Date:  2016-12-09       Impact factor: 42.937

7.  Outcome measures for clinical trials in fragile X syndrome.

Authors:  Elizabeth Berry-Kravis; David Hessl; Leonard Abbeduto; Allan L Reiss; Andrea Beckel-Mitchener; Tiina K Urv
Journal:  J Dev Behav Pediatr       Date:  2013-09       Impact factor: 2.225

8.  A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases.

Authors:  B Hagberg; J Aicardi; K Dias; O Ramos
Journal:  Ann Neurol       Date:  1983-10       Impact factor: 10.422

9.  Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome.

Authors:  J L Neul; P Fang; J Barrish; J Lane; E B Caeg; E O Smith; H Zoghbi; A Percy; D G Glaze
Journal:  Neurology       Date:  2008-03-12       Impact factor: 9.910

10.  Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndrome.

Authors:  Daniel G Glaze; Jeffrey L Neul; Walter E Kaufmann; Elizabeth Berry-Kravis; Sean Condon; George Stoms; Sean Oosterholt; Oscar Della Pasqua; Larry Glass; Nancy E Jones; Alan K Percy
Journal:  Neurology       Date:  2019-03-27       Impact factor: 9.910

View more
  7 in total

Review 1.  Clinical Trial Design for Disease-Modifying Therapies for Genetic Epilepsies.

Authors:  Dylan C Brock; Scott Demarest; Tim A Benke
Journal:  Neurotherapeutics       Date:  2021-09-30       Impact factor: 6.088

2.  Anthropometric Measures Correspond with Functional Motor Outcomes in Females with Rett Syndrome.

Authors:  Kathleen J Motil; Suzanne Geerts; Fran Annese; Jeffrey L Neul; Tim Benke; Eric Marsh; David Lieberman; Steven A Skinner; Daniel G Glaze; Peter Heydemann; Arthur Beisang; Shannon Standridge; Robin Ryther; Jane B Lane; Lloyd Edwards; Alan K Percy
Journal:  J Pediatr       Date:  2022-01-19       Impact factor: 6.314

Review 3.  Improving clinical trial readiness to accelerate development of new therapeutics for Rett syndrome.

Authors:  Helen Leonard; Wendy Gold; Rodney Samaco; Mustafa Sahin; Timothy Benke; Jenny Downs
Journal:  Orphanet J Rare Dis       Date:  2022-03-04       Impact factor: 4.123

Review 4.  GENE TARGET: A framework for evaluating Mendelian neurodevelopmental disorders for gene therapy.

Authors:  Maya Chopra; Meera E Modi; Kira A Dies; Nancy L Chamberlin; Elizabeth D Buttermore; Stephanie Jo Brewster; Lisa Prock; Mustafa Sahin
Journal:  Mol Ther Methods Clin Dev       Date:  2022-08-29       Impact factor: 5.849

5.  Electrophysiological biomarkers of brain function in CDKL5 deficiency disorder.

Authors:  Joni N Saby; Patrick J Mulcahey; Alexis E Zavez; Sarika U Peters; Shannon M Standridge; Lindsay C Swanson; David N Lieberman; Heather E Olson; Alexandra P Key; Alan K Percy; Jeffrey L Neul; Charles A Nelson; Timothy P L Roberts; Timothy A Benke; Eric D Marsh
Journal:  Brain Commun       Date:  2022-08-04

6.  Development and Psychometric Properties of the Multi-System Profile of Symptoms Scale in Patients with Rett Syndrome.

Authors:  Jatinder Singh; Federico Fiori; Mei Lin Law; Ruksana Ahmed; Shashidhar Ameenpur; Salah Basheer; Samiya Chishti; Rosie Lawrence; Mathilde Mastroianni; Abdolreza Mosaddegh; Paramala Santosh
Journal:  J Clin Med       Date:  2022-08-30       Impact factor: 4.964

7.  Phenotypic features in MECP2 duplication syndrome: Effects of age.

Authors:  Sarika U Peters; Cary Fu; Eric D Marsh; Tim A Benke; Bernard Suter; Steve A Skinner; David N Lieberman; Shannon Standridge; Mary Jones; Arthur Beisang; Timothy Feyma; Peter Heydeman; Robin Ryther; Daniel G Glaze; Alan K Percy; Jeffrey L Neul
Journal:  Am J Med Genet A       Date:  2020-11-10       Impact factor: 2.802

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.